Publicaciones (135) Publicaciones en las que ha participado algún/a investigador/a

2023

  1. A 20-year Follow-up of the International Early Lung Cancer Action Program (I-ELCAP)

    Radiology, Vol. 309, Núm. 2, pp. e231988

  2. A new FGF15/19-mediated gut-to-heart axis controls cardiac hypertrophy

    Journal of Pathology, Vol. 261, Núm. 3, pp. 335-348

  3. A prognostic score to identify women at increased risk for abnormal uterine bleeding during anticoagulation for venous thromboembolism

    Thrombosis Update, Vol. 13

  4. AG5 is a potent non-steroidal anti-inflammatory and immune regulator that preserves innate immunity

    Biomedicine and Pharmacotherapy, Vol. 169

  5. APLF and long non-coding RNA NIHCOLE promote stable DNA synapsis in non-homologous end joining

    Cell Reports, Vol. 42, Núm. 1

  6. Advancing with cancer immunotherapeutics: CD29+ regulatory T cell antagonism

    Gut

  7. Antagonic effect of ghrelin and LEAP-2 on hepatic stellate cell activation and liver fibrosis in obesity-associated nonalcoholic fatty liver disease

    European journal of endocrinology, Vol. 188, Núm. 7, pp. 564-577

  8. Application of a split-Cre system for high-capacity adenoviral vector amplification

    Biotechnology Journal, Vol. 18, Núm. 3

  9. Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab-bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study

    The Lancet. Oncology, Vol. 24, Núm. 12, pp. 1411-1422

  10. Assessment of Pre-Clinical Liver Models Based on Their Ability to Predict the Liver-Tropism of Adeno-Associated Virus Vectors

    Human gene therapy, Vol. 34, Núm. 7-8, pp. 273-288

  11. Association of Intima-Media Thickness Measured at the Common Carotid Artery With Incident Carotid Plaque: Individual Participant Data Meta-Analysis of 20 Prospective Studies

    Journal of the American Heart Association, Vol. 12, Núm. 12, pp. e027657

  12. Author Correction: Defective HNF4alpha-dependent gene expression as a driver of hepatocellular failure in alcoholic hepatitis (Nature Communications, (2019), 10, 1, (3126), 10.1038/s41467-019-11004-3)

    Nature Communications

  13. Bariatric Surgery Is Associated with Alcohol-Related Liver Disease and Psychiatric Disorders Associated with AUD

    Obesity Surgery, Vol. 33, Núm. 5, pp. 1494-1505

  14. Cambios en el perfil metabolómico en suero tras la cirugía curativa del cáncer de pulmón. Estudio PROMOTER

    Revista española de patología torácica, Vol. 35, Núm. 1, pp. 43-44

  15. Cardiac Progenitor Cell Exosomal miR-935 Protects against Oxidative Stress

    Cells, Vol. 12, Núm. 18

  16. Ceramide synthase 6 (CerS6) is upregulated in alcohol-associated liver disease and exhibits sex-based differences in the regulation of energy homeostasis and lipid droplet accumulation

    Molecular Metabolism, Vol. 78

  17. Checkpoint blockade meets gene therapy: Opportunities to improve response and reduce toxicity

    International Review of Cell and Molecular Biology (Elsevier Inc.), pp. 43-86

  18. Clinical Impact of Rapid Bacterial Microbiological Identification with the MALDI-TOF MS

    Antibiotics, Vol. 12, Núm. 12

  19. Clinical, dosimetric, and reporting considerations for Y-90 glass microspheres in hepatocellular carcinoma: updated 2022 recommendations from an international multidisciplinary working group

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 50, Núm. 2, pp. 328-343

  20. Combination immunotherapy for hepatocellular carcinoma

    Journal of Hepatology, Vol. 79, Núm. 2, pp. 506-515